ES2144399T3 - Clonado del adn de virus de anemia de los pollos. - Google Patents

Clonado del adn de virus de anemia de los pollos.

Info

Publication number
ES2144399T3
ES2144399T3 ES91917088T ES91917088T ES2144399T3 ES 2144399 T3 ES2144399 T3 ES 2144399T3 ES 91917088 T ES91917088 T ES 91917088T ES 91917088 T ES91917088 T ES 91917088T ES 2144399 T3 ES2144399 T3 ES 2144399T3
Authority
ES
Spain
Prior art keywords
anemia virus
cloning
cav
virus dna
chicken anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917088T
Other languages
English (en)
Inventor
Mathieu Hubertus Maria Noteborn
Gerben Foppe De Boer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadd BV
Original Assignee
Leadd BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd BV filed Critical Leadd BV
Application granted granted Critical
Publication of ES2144399T3 publication Critical patent/ES2144399T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

SE HA DESCUBIERTO LA INFORMACION GENETICA RECOMBINANTE (DNA O RNA), QUE COMPRENDE UNA SECUENCIA NUCLEOTIDA ESPECIFICA PARA EL VIRUS DE LA ANEMIA DE LA GALLINA Y EL USO DE LA MISMA PARA PRUEBAS DE DIAGNOSTICO, VACUNACION O PRODUCCION DE PROTEINA. ASIMISMO SE PRESNETA LA PROTEINA CAV RECOMBINANTE Y USO DE LA MISMA PARA PRUEBAS DE DIAGNOSTICO, VACUNACION Y PRODUCCION DE ANTICUERPOS ESPECIFICOS PARA EL CAV. ASIMISMO SE PRESENTA EL USO DE LOS ANTICUERPOS ESPECIFICOS PARA EL CAV ASI OBTENIDOS.
ES91917088T 1990-09-12 1991-09-11 Clonado del adn de virus de anemia de los pollos. Expired - Lifetime ES2144399T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.

Publications (1)

Publication Number Publication Date
ES2144399T3 true ES2144399T3 (es) 2000-06-16

Family

ID=19857669

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917088T Expired - Lifetime ES2144399T3 (es) 1990-09-12 1991-09-11 Clonado del adn de virus de anemia de los pollos.

Country Status (21)

Country Link
US (6) US5491073A (es)
EP (2) EP0905246A1 (es)
JP (1) JP2846116B2 (es)
AT (1) ATE188739T1 (es)
AU (1) AU651999B2 (es)
CA (1) CA2091181C (es)
DE (1) DE69131903T2 (es)
DK (1) DK0548234T3 (es)
ES (1) ES2144399T3 (es)
GR (1) GR3033173T3 (es)
HR (1) HRP940668B1 (es)
HU (1) HU220102B (es)
IL (1) IL99435A (es)
MX (1) MX9101042A (es)
NL (1) NL9002008A (es)
RU (1) RU2146292C1 (es)
SI (1) SI9111508B (es)
UA (1) UA48936C2 (es)
WO (1) WO1992004446A1 (es)
YU (1) YU49095B (es)
ZA (1) ZA917065B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
US20020061296A1 (en) * 2000-09-08 2002-05-23 Noteborn Mathieu H.M. Delivery method for the tumor specific apoptosis inducing activity of apoptin
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0878546A1 (en) * 1997-04-15 1998-11-18 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
WO1996040931A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Neutralizing conformational epitopes of chicken anemia virus
AU1075197A (en) * 1995-11-14 1997-06-05 Mark A. Goodwin Efficient method of detecting an infectious agent in blood
PL196605B1 (pl) 1997-08-12 2008-01-31 Leadd Bv Sposób oznaczania zdolności transformującej, sposób oznaczania predyspozycji do przekształcania się w komórkę nowotworową, sposób oznaczania predyspozycji do dziedziczenia rodzajów raka, sposób oznaczania mutacji genu i diagnostyczny zestaw testowy
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
CA2383784A1 (en) * 1999-09-02 2001-03-08 Leadd B.V. Apoptin-associating protein
WO2001042461A2 (en) * 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
CN1184922C (zh) * 2000-07-10 2005-01-19 尤妮佳股份有限公司 清扫物品
EP1199363A1 (en) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylation modifications of apoptin
AUPR567401A0 (en) * 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
CA2477811A1 (en) * 2001-09-05 2003-03-13 Biomune Chicken anemia virus vaccine from cell line
US7566548B2 (en) * 2004-08-13 2009-07-28 University Of Massachusetts Methods for identifying therapeutic agents and for treating disease
CN102636646A (zh) * 2012-05-15 2012-08-15 扬州大学 快速检测禽白血病抗原的试纸条及其制备方法
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
JP2022513459A (ja) * 2018-12-12 2022-02-08 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド タンパク質代替治療モダリティを送達するためのアネロソーム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS6032714A (ja) 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5079005A (en) 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
WO1990002803A2 (en) * 1988-09-13 1990-03-22 Rhone-Merieux S.A. Viral vaccines
GB2237510B (en) 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic

Also Published As

Publication number Publication date
SI9111508B (en) 2001-12-31
EP0905246A1 (en) 1999-03-31
MX9101042A (es) 1992-08-10
RU2146292C1 (ru) 2000-03-10
EP0548234B1 (en) 2000-01-12
HRP940668B1 (en) 2000-10-31
HU9300716D0 (en) 1993-06-28
US6319693B1 (en) 2001-11-20
DE69131903D1 (de) 2000-02-17
CA2091181C (en) 2006-02-21
HRP940668A2 (en) 1997-12-31
DE69131903T2 (de) 2000-07-20
GR3033173T3 (en) 2000-08-31
CA2091181A1 (en) 1992-03-13
SI9111508A (sl) 1998-10-31
JPH06504195A (ja) 1994-05-19
NL9002008A (nl) 1992-04-01
AU651999B2 (en) 1994-08-11
ATE188739T1 (de) 2000-01-15
DK0548234T3 (da) 2000-06-19
JP2846116B2 (ja) 1999-01-13
US5932476A (en) 1999-08-03
UA48936C2 (uk) 2002-09-16
US6509446B2 (en) 2003-01-21
AU8658091A (en) 1992-03-30
IL99435A0 (en) 1992-08-18
US6238669B1 (en) 2001-05-29
US5958424A (en) 1999-09-28
YU49095B (sh) 2003-12-31
YU150891A (sh) 1995-10-24
US5491073A (en) 1996-02-13
WO1992004446A1 (en) 1992-03-19
HU220102B (hu) 2001-10-28
HUT65974A (en) 1994-08-29
US20020103336A1 (en) 2002-08-01
EP0548234A1 (en) 1993-06-30
ZA917065B (en) 1992-05-27
IL99435A (en) 2006-10-31

Similar Documents

Publication Publication Date Title
YU150891A (sh) Rekombinantna genetska informacija
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
ATE26127T1 (de) Rekombinante dna, damit transformierte wirtsorganismen und durch die wirtsorganismen hergestellte polypeptide; verfahren zu ihrer herstellung; nachweisverfahren unter benutzung der polypeptide; die polypeptide enthaltende zusammensetzungen und mittel; dna-sequenzen.
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
DE69638162D1 (de) Bindegewebs wachstumsfaktor (ctgf)
DE69835143D1 (de) Selektion von proteinen mittels rns-protein fusionen
BR9811039A (pt) Citocina de mamìferos: interleucina-b30 e reagentes relacionados
AR038568A1 (es) Anticuerpos anti-a beta y su uso
RU93005170A (ru) Нуклеиновые кислоты, применение нуклеиновых кислот, диагностические наборы, вакцины, клетки, белок, применение белка, антитела, применение антител
ES2061500T3 (es) Diagnosis y vacunas de la hepatitis delta su preparacion y uso.
DE68929467D1 (de) HIV-2 Varianten
ES2010538A6 (es) Procedimiento para la preparacion de un gen sintetico.
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69840445D1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
DE69728897D1 (de) Saeugetierchemokine
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ATE180489T1 (de) Für leberzellkarzinom spezifisches onkogen
FI850814A7 (fi) Proteiineja, farmaseuttisia seoksia, geenejä, vektoreita, isäntäorgan ismeja ja menetelmiä niiden tuottamiseksi.
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
DE69301733D1 (de) Impfstoffe gegen Metazoen-Parasiten
ATE294237T1 (de) S?ugetier thymokingene
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 548234

Country of ref document: ES